Crumly & Associates Inc. Boston Scientific Corp Transaction History

Crumly & Associates Inc.

$333 Million
Q2 2025

A detailed history of Crumly & Associates Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Crumly & Associates Inc. holds 5,993 shares of BSX stock, worth $625,189. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,993

Previous 7,695 22.12%

Holding current value

$625,189

Previous $776,000 17.14%

% of portfolio

0.19%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 02, 2025	SELL	$89.7 - $107.41 $152,669 - $182,811	-1,702 Reduced 22.12%	5,993 $643,000
Q1 2025 Apr 22, 2025	SELL	$89.38 - $106.18 $115,836 - $137,609	-1,296 Reduced 14.41%	7,695 $776,000
Q4 2024 Feb 03, 2025	SELL	$83.62 - $91.5 $6,020 - $6,588	-72 Reduced 0.79%	8,991 $803,000
Q3 2024 Nov 01, 2024	SELL	$72.96 - $84.0 $12,476 - $14,364	-171 Reduced 1.85%	9,063 $759,000
Q2 2024 Aug 02, 2024	SELL	$67.33 - $77.71 $23,430 - $27,043	-348 Reduced 3.63%	9,234 $711,000
Q1 2024 May 01, 2024	SELL	$57.6 - $68.62 $8,985 - $10,704	-156 Reduced 1.6%	9,582 $656,000
Q4 2023 Jan 29, 2024	BUY	$48.64 - $57.81 $2,286 - $2,717	47 Added 0.48%	9,738 $562,000
Q4 2023 Jan 29, 2024	BUY	$48.64 - $57.81 $72,960 - $86,715	1,500 Added 18.31%	9,691 $560,000
Q3 2023 Nov 02, 2023	SELL	$50.19 - $54.68 $602 - $656	-12 Reduced 0.15%	8,191 $432,000
Q2 2023 Jul 21, 2023	BUY	$49.72 - $54.64 $133,995 - $147,254	2,695 Added 48.93%	8,203 $443,000
Q1 2023 Apr 24, 2023	BUY	$45.09 - $50.03 $1,397 - $1,550	31 Added 0.57%	5,508 $275,000
Q4 2022 Mar 03, 2023	BUY	$39.56 - $47.22 $216,670 - $258,623	5,477 New	5,477 $253,000

Others Institutions Holding BSX

# of Institutions

1,834

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $149B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crumly & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crumly & Associates Inc. with notifications on news.

Account

Crumly & Associates Inc. Boston Scientific Corp Transaction History